Last update:

Oncology & Cancer news

Oncology & Cancer

Mutation yields hot new clues for treating immune 'cold' tumors

Immune checkpoint inhibitors (ICIs) emerged in the US about 15 years ago as an exciting class of cancer treatments that have achieved complete and durable remissions for thousands of people with end-stage metastatic cancers. ...

Oncology & Cancer

Capturing cancer cells from blood could help doctors choose the right breast cancer treatment

Doctors may be able to spare patients unnecessarily aggressive breast cancer treatments by collecting and testing cancer cells in patients' blood, research from the University of Michigan and the University of Kansas suggests.

Oncology & Cancer

Why are so many millennials getting cancer?

If you're reading this, there's a good chance that you, like me, are a millennial. If so, you've probably noticed more and more cases of friends or acquaintances with diseases that you would normally associate with later ...

Oncology & Cancer

Radiation therapy for patients with breast cancer

Radiation therapy is a common component of breast cancer treatment for patients. The high-powered beams of intense energy kill cancer cells and reduce the risk of the cancer recurring.

Oncology & Cancer

In-surgery radiation cuts pancreatic cancer return

Using targeted radiation during surgery—referred to as intraoperative radiation—to eliminate pancreatic cancer cells that have spread to areas around the pancreas, investigators at Johns Hopkins have been able to reduce ...

Oncology & Cancer

AI tool identifies women at high risk of interval breast cancer

In a study of more than 100,000 screening mammograms, researchers demonstrated the potential of an AI tool to help identify women at higher risk of developing interval breast cancer, which is breast cancer that is diagnosed ...

Oncology & Cancer

Study reveals targeted therapy for aggressive liver cancer

Among the many forms of liver cancer, hepatocellular carcinoma (HCC) is the most common and one of the leading causes of cancer-related deaths worldwide. It is a complex disease with multiple aggressive subtypes that are ...

Medications

Boehringer wins US approval for cancer drug

Boehringer Ingelheim GmbH won approval in the U.S. for its drug to treat a challenging form of lung cancer, offering a growth avenue for the privately-held German pharmaceuticals company.

Oncology & Cancer

Hidden bowel cancer risk in common growths

Flinders University and Flinders Medical Center researchers have found a critical link between having two types of polyps, common growths found in the bowel, and an increased risk of developing cancer, according to a new ...

Oncology & Cancer

Colorectal cancer study expands and optimizes 3D tumor models

Researchers from the Germans Trias i Pujol Research Institute (IGTP) have published a study in Scientific Reports that provides an analysis of three-dimensional (3D) culture techniques for generating multicellular tumor spheroids ...